Tata Memorial Centre s opinion is summarized as follows:

Similar documents
What is the recommended regimen for adjuvant radiation therapy? Tata Memorial Centre s opinion is summarized as follows:

Tata Memorial Centre s opinion is summarized as follows: We hope that the expert opinion is helpful in determining the course of your treatment.

Tata Memorial Centre s opinion is summarized as follows: 1. Given the type 1 stricture (as mentioned in the structured summary), assessment

The TMC NCG Navya opinion is summarized as follows:

Yes, the PET-CT report dated April 13 th 2016 was included in the structured summary reviewed by a medical oncologist at Tata Memorial Centre.

The TMC NCG Navya opinion is summarized as follows: or CTLA4 inhibitors (such as Iplimumab) may be considered.

The given bone scan and the PSA reports (as mentioned in the structured summary), suggests metastatic prostate cancer which has spread to the bones.

Surgery for Breast Cancer

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Breast Cancer. Saima Saeed MD

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

Debate Axillary dissection - con. Prof. Dr. Rodica Anghel Institute of Oncology Bucharest

Presented by: Lillian Erdahl, MD

ACRIN 6666 Therapeutic Surgery Form

My Personalized Breast Cancer Worksheet

Ductal Carcinoma-in-Situ: New Concepts and Controversies

Breast cancer incidence. Multidisciplinary Management in Breast Cancer. Outline. The Breast 11/10/2014. Incidence of breast cancer in Thailand

Maria João Cardoso, MD, PhD

COPE Library Sample

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

Breast cancer: an update

Breast Cancer Update 2018 The Latest in Diagnosis and Treatment SARATH K, PALAKODETI, DO, FAACS GENERAL, BREAST, AND COSMETIC SURGEON TOLEDO CLINIC

Breast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina

It is a malignancy originating from breast tissue

Breast Cancer in Women

BreastScreen Aotearoa Annual Report 2015

Quiz. b. 4 High grade c. 9 Unknown

Breast Cancer Diagnosis, Treatment and Follow-up

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Breast Cancer. What is breast cancer?

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

Conservative Surgery and Radiation Stage I and II Breast Cancer

Breast Cancer. For breast cancer, the mortality risk varies with the stage of the cancer.

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

3D Conformal Radiation Therapy for Mucinous Carcinoma of the Breast

What is the Oncotype DX test?

Tata Memorial Hospital - Mumbai, India

Breast Cancer Surgery Options

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction

Locally-Advanced Ulcerative T4b Breast Cancer; Are Reconstructive Attempts Feasible?

Health Bites Breast Cancer. Breast Cancer. Normal breast

University Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina

RADIOTHERAPY IN BREAST CANCER :

Jose A Torres, MD 1/12/2017

Clinical and pathological portraits of axillary presentation breast cancer and effects of preoperative systemic therapy

Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography

Mucinous breast cancer

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

Time to Start Adjuvant Systemic Treatment in Breast Cancer; a Retrospective Cohort Study

Key Ouestions. to ask your medical oncology team after being diagnosed with breast cancer

ARROCase - April 2017

How can surgeons help the Radiation Oncologists?

PATIENT INFORMATION. about BREAST CANCER

Pathology Report Patient Companion Guide

One Breast Cancer Annual Report

CASE REPORT GASTRIC ADENOCARCINOMA METASTASIS TO THE BREAST- A DIFFERENTIAL DIAGNOSIS WITH PRIMARY BREAST ADENOCARCINOMA AND REVIEW OF LITERATURE.

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

BREAST CANCER SURGERY. Dr. John H. Donohue

Breast Surgery: Yesterday, Today and Tomorrow

Koebner Phenomenon in Radiation Associated Angiosarcoma of the Breast: Linear Metastasis in Split Skin Graft Donor Site

Page 1. AHN-JHU Breast Cancer Symposium. Novel Local Regional Clinical Trials. Background. Neoadjuvant Chemotherapy Benefit.

Classification System

Cancer Endorsement Maintenance 2011-Maintenance Measures

National Center of Oncology - Yerevan, Armenia

Breast Reconstruction Guidebook for

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues

The Alvin & Lois Lapidus Cancer Institute BREAST CANCER

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

BREAST CANCER CARE IN RESOURCE CONSTRAINED REGIONS BBCC 2017 DHAKA. M.J.PAUL MS,DNB, FRCS (Glasg) Professor, Endocrine Surgery CMC Vellore, India

Results of the ACOSOG Z0011 Trial

Breast Cancer Task Force of the Greater Miami Valley A collaborative effort of health care professionals and breast cancer survivors in the Greater

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Breast Cancer. What is breast cancer?

Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer May 5, 2006

Pathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

AMSER Case of the Month: November 2018

BRCA mutation carrier patient: How to manage?

NCIN Breast Cancer Workshop 13 March 2014 Hilton Metropole, NEC, Birmingham. Kieran Horgan, Dick Rainsbury, Mark Sibbering, Gill lawrence

2016 Uterine Cancer Annual Report

Dyson Center for Cancer Care - Poughkeepsie, New York, United States of America

Pregnancy in the middle of adjuvant treatment of Her2 positive breast cancer

Discussing Fertility Preservation with Breast Cancer Patients

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

Chief Investigator Adele Francis University of Birmingham UK. Prof MWR Reed (CoI) University of Sheffield

NATIONAL QUALITY FORUM

Breast Cancer Breast Managed Clinical Network

Patient Guide to Breast Cancer Surgery and Treatment

Watchful Waiting: Well Behaved Breast Cancers Non-Surgical Management of Breast Cancer

September 9, IORT Shows Promise in Early Use

Transcription:

February 2 nd 2015 Dear Ms., Thank you for reaching out to Tata Memorial Centre for an expert opinion in regard to assessing your treatment options. Navya Network is pleased to offer this online consultation service for Tata Memorial Centre. We converted your case reports into a structured summary to be reviewed by a surgical oncologist in the Breast Disease Management Group at Tata Memorial Centre. We asked the following question(s) on your behalf: 1. Is Breast Conservation Therapy (BCT), which includes Lumpectomy (i.e. removal only of the cancerous tumor/lump in the breast) and radiation therapy, if feasible, safer than Modified Radical Mastectomy (MRM), which includes Mastectomy (i.e. complete removal of breast) with Axillary Lymph Node Dissection (ALND) (i.e. axillary clearance)? 2. Are additional diagnostic tests necessary? Tata Memorial Centre s opinion is summarized as follows: 1. If breast conservation is desired then review of the mammography images by a surgical oncologist is recommended in order to determine whether Lumpectomy for Breast Conservation Therapy (BCT) is feasible. 2. Review of the mammography images is necessary to confirm that microcalcification (i.e. deposits of calcium that may or may not be cancerous) is contained (i.e. restricted within) to the outer half of the right breast, and the tumor/lesion noted at the 3 o clock position in the breast is benign i.e. not cancerous. 3. If microcalcification is contained within the outer half of the breast and the tumor/lesion noted at 3 o clock is benign, then Lumpectomy, which includes, which includes excision of the outer half of the right breast (i.e., removal of the outer half) and immediate reconstruction Lat Dorsi flap (LD flap) is recommended. Otherwise Modified Radical Mastectomy (MRM) is recommended. 4. After surgery, adjuvant chemotherapy is recommended 5. Adjuvant Loco Regional Radiation Therapy (LRRT) is recommended. We hope that the expert opinion is helpful in determining the course of your treatment. Please discuss this opinion with your local treating surgical oncologist. You may reach out to us with your mammography images, if you would like the experts at Tata Memorial Centre to review the mammography images and reconfirm the treatment plan for surgery. Navya Network Inc does not diagnose, treat, give orders, or have the ultimate authority over the care of any individuals. Page 1

Please note that for Breast Conservation Therapy (BCT), postoperative radiation is always necessary after Lumpectomy (surgical removal of only the cancerous tumor/lump in the breast). You may discuss the specifics of radiation therapy with your radiation oncologist. Please do not hesitate to write to us or call us with any questions. Sincerely, Gitika Srivastava Navya Network Inc does not diagnose, treat, give orders, or have the ultimate authority over the care of any individuals. Page 2

CASE SUMMARY Navya ID Expert Opinion ID, Ms.. Age: 29 Years Old Clinical Diagnosis: Operable Breast Cancer (OBC) Menopausal Status: Pre-Menopausal Initial Clinical Tumor Size 1(cm): 2.00 Initial Clinical Tumor Size 2 (cm): 2.00 Axillary Clinical Lymph Nodes: Yes Desires BCT: Yes Breast Size: 32 (Moderate) Breast Cancer Laterality: Right Upper Outer Quadrant: Yes Chest X-Ray: January 18th 2015 Chest X-Ray: Normal Abdomen / Pelvis US Date: January 18th 2015 Abdomen/ Pelvis US: Normal Diagnosis Made By: Excisional Biopsy Malignant Breast Disease: Invasive Ductal Carcinoma (IDC) Cancer Grade: III Modified Richardson Bloom Score : 8 Lymphovascular Invasion: Negative Estrogen Receptors ER - Status: Negative Progesterone Receptors PR - Status: Negative Navya Network Inc does not diagnose, treat, give orders, or have the ultimate authority over the care of any individuals. Page 3

HER 2 NEU Receptors - Status: Intermediate HER 2 NEU Receptors - IHC: 2+ Initial Ultrasound Size Date: January 19th 2015 Initial Ultrasound Size1 (cm): 0.57 Initial Ultrasound Size2 (cm): 0.40 Initial Ultrasound Size Text: Rt breast scar seen from 8-11 o'clock position; Small nodule seen at 9 o'clock along medial aspect-?microcalcification-birads-iv; Nodules seen at 12 and 3 o'clock position- BIRAD II; Rt axillary lymphadenopathy seen Functional Status- ECOG Score: 0 Bone Marrow (Hematologic) Function : Adequate Kidney (Renal) Function : Adequate Liver (Hepatic) Function: Adequate Planned Treatment: Timing Primary Treatment MRM- Modified Radical Mastectomy Navya Network Inc does not diagnose, treat, give orders, or have the ultimate authority over the care of any individuals. Page 4

Navya Network is a Cambridge, MA based company with offices in Bangalore, India. Navya Network is founded by graduates of Harvard University, MIT Sloan School of Management, and the Stanford School of Medicine. Navya s innovative and scalable decision making system is a technology powered solution for complex medical questions. Navya s software solutions are efficient engines to gather and synthesize individual goals of care, evidence specific to an individual medical case, and expert opinion, for evaluating treatment alternatives. Navya s goal is to assist in bringing clarity to the complexity of evaluating treatment alternatives. Navya s system collects the best available information and expertise from several worldwide sources relevant to a specific previously diagnosed medical case and assesses treatment decisions. For more information, please visit www.navyanetwork.com If you have any questions, please call +91 9845423460 or email gitika@navyatech.in Navya Network, Inc does not diagnose, prescribe medication, treat, or give orders, nor does Navya have the ultimate authority over the care of any individuals. Navya does not provide medical advice nor does its products, services, systems, projects, or programs constitute the practice of medicine, nursing, or any other health care profession. Any information provided by Navya as a result of use of Navya s products, services, systems, projects, or programs is being provided solely for educational and informational benefit and should not be considered diagnosis, treatment or a substitute for professional medical advice. Use of Navya s products, services, systems, projects, or programs does not establish a doctor-patient relationship. Navya encourages that individuals or patients using Navya s products, services, systems, projects, or programs share any reports or other information generated by the use of Navya s products, services, systems, projects, or programs with their treating health care provider. Use of Navya s products, services, systems, projects, or programs is voluntary and any information communicated as a result of the use of Navya s products, services, systems, projects, or programs is not intended to be, nor implied to be, and cannot and should not be used as a substitute for professional medical advice, diagnosis or treatment. Navya s products, services, systems, projects, or programs are limited to the provision of consultative services with respect to known or previously-identified condition and neither Navya, nor its employees, consultants or agents with whom it contracts will diagnose, treat, give orders, prescribe medications or have any authority over the care of any individuals. Navya s products, services, systems, projects, or programs will not involve any direct face-to-face encounters or physical examinations. Accordingly, individuals using Navya s products, services, systems, projects, or programs are encouraged to share and discuss any information provided as a result of use of Navya s products, services, systems, projects, or programs with their treating physician. The individuals or patients using Navya s products, services, systems, projects, or programs will be the ultimate decision maker over their own care. Navya Network Inc does not diagnose, treat, give orders, or have the ultimate authority over the care of any individuals. Page 5

INDIVIDUALS OR PATIENTS USING NAVYA S PRODUCTS, SERVICES, SYSTEMS, PROJECTS, OR PROGRAMS SHOULD NEVER DELAY OR AVOID SEEKING MEDICAL ADVICE OR ATTENTION FROM THEIR REGULAR HEALTH CARE PROVIDER OR TREATING PHYSICIAN OR DOCTOR BECAUSE OF SOMETHING THEY HAVE LEARNED THROUGH THEIR USE OF NAVYA S PRODUCTS, SERVICES, SYSTEMS, PROJECTS, OR PROGRAMS. SHOULD ANY UNEXPECTED MEDICAL EVENT OCCUR WHILE AN INDIVIDUAL OR A PATIENT IS PARTICIPATING IN THE USE OF NAVYA S PRODUCTS, SERVICES, SYSTEMS, PROJECTS, OR PROGRAMS, THE INDIVIDUAL OR THE PATIENT SHOULD IMMEDIATELY CALL THEIR HEALTH CARE PROVIDER OR TREATING PHYSICIAN OR DOCTOR OR LOCAL EMERGENCY ASSISTANCE NUMBER OR IMMEDIATELY VISIT THEIR LOCAL EMERGENCY ROOM. Navya Network Inc does not diagnose, treat, give orders, or have the ultimate authority over the care of any individuals. Page 6